{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:29:19Z","timestamp":1775636959331,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10787-021-00829-4","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T18:02:52Z","timestamp":1625335372000},"page":"1101-1109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Revisiting bupropion anti-inflammatory action: involvement of the TLR2\/TLR4 and JAK2\/STAT3"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6684-333X","authenticated-orcid":false,"given":"Alireza","family":"Karimollah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5014-8183","authenticated-orcid":false,"given":"Anahid","family":"Hemmatpur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Vahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"key":"829_CR1","first-page":"186","volume":"3","author":"A Akpinar","year":"2013","unstructured":"Akpinar A, Ceyhan MA, Yaman AR (2013) Psoriasis triggered by bupropion in a patient with major depression. Psychiatry Behav Sci 3:186","journal-title":"Psychiatry Behav Sci"},{"key":"829_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/169203","author":"B Arosio","year":"2014","unstructured":"Arosio B, D\u2019Addario C, Gussago C, Casati M, Tedone E, Ferri E, Nicolini P, Rossi PD, Maccarrone M, Mari D (2014) Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly. BioMed Res Int. https:\/\/doi.org\/10.1155\/2014\/169203","journal-title":"BioMed Res Int"},{"key":"829_CR3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fpsyt.2019.00458","volume":"10","author":"G Arteaga-Henr\u00edquez","year":"2019","unstructured":"Arteaga-Henr\u00edquez G, Simon MS, Burger B, Weidinger E, Wijkhuijs A, Arolt V, Birkenhager TK, Musil R, M\u00fcller N, Drexhage HA (2019) Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-Moodinflame Consortium. Front Psych 10:458","journal-title":"Front Psych"},{"key":"829_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.intimp.2005.12.007","volume":"6","author":"D Brustolim","year":"2006","unstructured":"Brustolim D, Ribeiro-Dos-santos R, Kast R, Altschuler E, Soares MBP (2006) A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 6:903\u2013907","journal-title":"Int Immunopharmacol"},{"key":"829_CR5","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1016\/j.transproceed.2013.04.010","volume":"45","author":"C C\u00e1mara-Lemarroy","year":"2013","unstructured":"C\u00e1mara-Lemarroy C, Guzm\u00e1n-de La garza F, Cordero-P\u00e9rez P, Alarc\u00f3n-Galv\u00e1n G, Ibarra-Hern\u00e1ndez J, Mu\u00f1oz-Espinosa L, Fern\u00e1ndez-Garza N (2013) Bupropion reduces the inflammatory response and intestinal injury due to ischemia-reperfusion. Transpl Proc 45:2502\u20132505","journal-title":"Transpl Proc"},{"key":"829_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-019-0665-5","volume":"10","author":"A Cattaneo","year":"2020","unstructured":"Cattaneo A, Ferrari C, Turner L, Mariani N, Enache D, Hastings C, Kose M, Lombardo G, McLaughlin AP, Nettis MA (2020) Whole-blood expression of inflammasome-and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study. Transl Psychiatry 10:1\u201314","journal-title":"Transl Psychiatry"},{"key":"829_CR7","first-page":"184","volume":"3","author":"A Cefle","year":"2006","unstructured":"Cefle A, Yazici A (2006) Bupropion hydrochloride induced serum sickness-like reaction. Eur J Gen Med 3:184\u2013185","journal-title":"Eur J Gen Med"},{"key":"829_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/1043-4666(92)90062-V","volume":"4","author":"D de Groote","year":"1992","unstructured":"de Groote D, Zangerl\u00e9 P-F, Gevaert Y, Fassotte M-F, Beguin Y, Noizat-Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I (1992) Direct stimulation of cytokines (IL-1\u03b2, TNF-\u03b1, IL-6, IL-2, IFN-\u03b3 and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4:239\u2013248","journal-title":"Cytokine"},{"key":"829_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbi.2012.10.008","volume":"31","author":"N Dellagioia","year":"2013","unstructured":"Dellagioia N, Devine L, Pittman B, Hannestad J (2013) Bupropion pre-treatment of endotoxin-induced depressive symptoms. Brain Behav Immun 31:197\u2013204","journal-title":"Brain Behav Immun"},{"key":"829_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11596-020-2193-1","volume":"40","author":"S-L Deng","year":"2020","unstructured":"Deng S-L, Chen J-G, Wang F (2020) Microglia: a central player in depression. Curr Med Sci 40:391\u2013400","journal-title":"Curr Med Sci"},{"key":"829_CR11","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/0269881108091077","volume":"23","author":"T Eller","year":"2009","unstructured":"Eller T, Vasar V, Shlik J, Maron E (2009) Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder. J Psychopharmacol 23:854\u2013858","journal-title":"J Psychopharmacol"},{"key":"829_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jneumeth.2012.05.025","volume":"209","author":"S Etemad","year":"2012","unstructured":"Etemad S, Zamin RM, Ruitenberg MJ, Filgueira L (2012) A novel in vitro human microglia model: characterization of human monocyte-derived microglia. J Neurosci Methods 209:79\u201389","journal-title":"J Neurosci Methods"},{"key":"829_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.5021\/ad.2015.27.3.334","volume":"27","author":"A Evrensel","year":"2015","unstructured":"Evrensel A, Ceylan ME (2015) Letters to the editor: bupropion-induced erythema multiforme. Ann Dermatol 27:334\u2013335","journal-title":"Ann Dermatol"},{"key":"829_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11096-013-9803-y","volume":"35","author":"M Garc\u00eda","year":"2013","unstructured":"Garc\u00eda M, Ruiz B, Aguirre C, Etxegarai E, Lertxundi U (2013) Eosinophilia associated with bupropion. Int J Clin Pharm 35:532\u2013534","journal-title":"Int J Clin Pharm"},{"key":"829_CR15","doi-asserted-by":"publisher","first-page":"e0150858","DOI":"10.1371\/journal.pone.0150858","volume":"11","author":"D Gonzalez-Pena","year":"2016","unstructured":"Gonzalez-Pena D, Nixon SE, O\u2019Connor JC, Southey BR, Lawson MA, McCusker RH, Borras T, Machuca D, Hernandez AG, Dantzer R (2016) Microglia transcriptome changes in a model of depressive behavior after immune challenge. PLoS ONE 11:e0150858","journal-title":"PLoS ONE"},{"key":"829_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.05.026","volume":"95","author":"E Haroon","year":"2018","unstructured":"Haroon E, Daguanno AW, Woolwine BJ, Goldsmith DR, Baer WM, Wommack EC, Felger JC, Miller AH (2018) Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder. Psychoneuroendocrinology 95:43\u201349","journal-title":"Psychoneuroendocrinology"},{"key":"829_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.yrtph.2018.08.001","volume":"98","author":"A Helaly","year":"2018","unstructured":"Helaly A, Mokhtar N, Firgany AE-DL, Hazem NM, el Morsi E, Ghorab D (2018) Molybdenum bupropion combined neurotoxicity in rats. Regul Toxicol Pharmacol 98:224\u2013230","journal-title":"Regul Toxicol Pharmacol"},{"key":"829_CR18","doi-asserted-by":"publisher","first-page":"e60388","DOI":"10.1371\/journal.pone.0060388","volume":"8","author":"DJ Hines","year":"2013","unstructured":"Hines DJ, Choi HB, Hines RM, Phillips AG, Macvicar BA (2013) Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides. PLoS ONE 8:e60388","journal-title":"PLoS ONE"},{"key":"829_CR19","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00213-015-4087-7","volume":"233","author":"Y-Y Hung","year":"2016","unstructured":"Hung Y-Y, Huang K-W, Kang H-Y, Huang GY-L, Huang T-L (2016) Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder. Psychopharmacology 233:1707\u20131714","journal-title":"Psychopharmacology"},{"key":"829_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbi.2016.09.014","volume":"59","author":"Y-Y Hung","year":"2017","unstructured":"Hung Y-Y, Lin C-C, Kang H-Y, Huang T-L (2017) TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder. Brain Behav Immun 59:265\u2013272","journal-title":"Brain Behav Immun"},{"key":"829_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.bbi.2017.07.005","volume":"66","author":"MK Jha","year":"2017","unstructured":"Jha MK, Minhajuddin A, Gadad BS, Greer TL, Mayes TL, Trivedi MH (2017) Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: novel T cell biomarker for antidepressant medication selection. Brain Behav Immun 66:103\u2013110","journal-title":"Brain Behav Immun"},{"key":"829_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000077851","volume":"208","author":"N Jumez","year":"2004","unstructured":"Jumez N, Dereure O, Bessis D, Guillot B (2004) Flare of cutaneous lupus erythematosus induced by bupropion (Zyban\u00ae). Dermatology 208:362\u2013362","journal-title":"Dermatology"},{"key":"829_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4306\/pi.2013.10.3.294","volume":"10","author":"J-W Kim","year":"2013","unstructured":"Kim J-W, Kim Y-K, Hwang J-A, Yoon H-K, Ko Y-H, Han C, Lee H-J, Ham B-J, Lee HS (2013) Plasma levels of IL-23 and IL-17 before and after antidepressant treatment in patients with major depressive disorder. Psychiatry Investig 10:294","journal-title":"Psychiatry Investig"},{"key":"829_CR24","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.genhosppsych.2011.07.001","volume":"33","author":"S Kumar","year":"2011","unstructured":"Kumar S, Kodela S, Detweiler JG, Kim KY, Detweiler MB (2011) Bupropion-induced psychosis: folklore or a fact? A systematic review of the literature. Gen Hosp Psychiatry 33:612\u2013617","journal-title":"Gen Hosp Psychiatry"},{"key":"829_CR25","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1038\/npp.2017.93","volume":"42","author":"S-H Kwon","year":"2017","unstructured":"Kwon S-H, Han J-K, Choi M, Kwon Y-J, Kim SJ, Yi EH, Shin J-C, Cho I-H, Kim B-H, Kim SJ (2017) Dysfunction of microglial STAT3 alleviates depressive behavior via neuron-microglia interactions. Neuropsychopharmacology 42:2072\u20132086","journal-title":"Neuropsychopharmacology"},{"key":"829_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"X-J Li","year":"2017","unstructured":"Li X-J, Ma Q-Y, Jiang Y-M, Bai X-H, Yan Z-Y, Liu Q, Pan Q-X, Liu Y-Y, Chen J-X (2017) Xiaoyaosan exerts anxiolytic-like effects by down-regulating the TNF-\u03b1\/JAK2-STAT3 pathway in the rat hippocampus. Sci Rep 7:1\u201313","journal-title":"Sci Rep"},{"key":"829_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1475-7","volume":"16","author":"C-H Liu","year":"2019","unstructured":"Liu C-H, Zhang G-Z, Li B, Li M, Woelfer M, Walter M, Wang L (2019) Role of inflammation in depression relapse. J Neuroinflammation 16:1\u201311","journal-title":"J Neuroinflammation"},{"key":"829_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fnins.2014.00309","volume":"8","author":"J Liu","year":"2014","unstructured":"Liu J, Buisman-Pijlman F, Hutchinson MR (2014) Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder. Front Neurosci 8:309","journal-title":"Front Neurosci"},{"key":"829_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"S Liu","year":"2016","unstructured":"Liu S, Li Q, Zhang M-T, Mao-Ying Q-L, Hu L-Y, Wu G-C, Mi W-L, Wang Y-Q (2016) Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1\u03b2 via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling. Sci Rep 6:1\u201314","journal-title":"Sci Rep"},{"key":"829_CR30","doi-asserted-by":"publisher","first-page":"101470","DOI":"10.1016\/j.mcp.2019.101470","volume":"48","author":"D Lou","year":"2019","unstructured":"Lou D, Wang J, Wang X (2019) miR-124 ameliorates depressive-like behavior by targeting STAT3 to regulate microglial activation. Mol Cell Probes 48:101470","journal-title":"Mol Cell Probes"},{"key":"829_CR31","doi-asserted-by":"publisher","first-page":"e77227","DOI":"10.1371\/journal.pone.0077227","volume":"8","author":"IS Maciel","year":"2013","unstructured":"Maciel IS, Silva RB, Morrone FB, Calixto JB, Campos MM (2013) Synergistic effects of celecoxib and bupropion in a model of chronic inflammation-related depression in mice. PLoS ONE 8:e77227","journal-title":"PLoS ONE"},{"key":"829_CR32","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/genes11091089","volume":"11","author":"E Maffioletti","year":"2020","unstructured":"Maffioletti E, Minelli A, Tardito D, Gennarelli M (2020) Blues in the brain and beyond: molecular bases of major depressive disorder and relative pharmacological and non-pharmacological treatments. Genes 11:1089","journal-title":"Genes"},{"key":"829_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/157015912800604542","volume":"10","author":"M Martino","year":"2012","unstructured":"Martino M, Rocchi G, Escelsior A, Fornaro M (2012) Immunomodulation mechanism of antidepressants: interactions between serotonin\/norepinephrine balance and Th1\/Th2 balance. Curr Neuropharmacol 10:97\u2013123","journal-title":"Curr Neuropharmacol"},{"key":"829_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3389\/fnins.2018.00547","volume":"12","author":"EM Medina-Rodriguez","year":"2018","unstructured":"Medina-Rodriguez EM, Lowell JA, Worthen RJ, Syed SA, Beurel E (2018) Involvement of innate and adaptive immune systems alterations in the pathophysiology and treatment of depression. Front Neurosci 12:547","journal-title":"Front Neurosci"},{"key":"829_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.phrs.2018.12.004","volume":"141","author":"SM Nabavi","year":"2019","unstructured":"Nabavi SM, Ahmed T, Nawaz M, Devi KP, Balan DJ, Pittal\u00e0 V, Arg\u00fcelles-Castilla S, Testai L, Khan H, Sureda A (2019) Targeting STATs in neuroinflammation: the road less traveled! Pharmacol Res 141:73\u201384","journal-title":"Pharmacol Res"},{"key":"829_CR36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.neuron.2018.06.035","volume":"99","author":"X Nie","year":"2018","unstructured":"Nie X, Kitaoka S, Tanaka K, Segi-Nishida E, Imoto Y, Ogawa A, Nakano F, Tomohiro A, Nakayama K, Taniguchi M (2018) The innate immune receptors TLR2\/4 mediate repeated social defeat stress-induced social avoidance through prefrontal microglial activation. Neuron 99:464\u2013479","journal-title":"Neuron"},{"key":"829_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep04957","volume":"4","author":"M Ohgidani","year":"2014","unstructured":"Ohgidani M, Kato TA, Setoyama D, Sagata N, Hashimoto R, Shigenobu K, Yoshida T, Hayakawa K, Shimokawa N, Miura D (2014) Direct induction of ramified microglia-like cells from human monocytes: dynamic microglial dysfunction in Nasu-Hakola disease. Sci Rep 4:1\u20137","journal-title":"Sci Rep"},{"key":"829_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/2045125316629071","volume":"6","author":"K Patel","year":"2016","unstructured":"Patel K, Allen S, Haque MN, Angelescu I, Baumeister D, Tracy DK (2016) Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Ther Adv Psychopharmacol 6:99\u2013144","journal-title":"Ther Adv Psychopharmacol"},{"key":"829_CR39","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s10753-020-01273-2","volume":"43","author":"A Rashidian","year":"2020","unstructured":"Rashidian A, Dejban P, Fard KK, Abdollahi A, Chamanara M, Dehpour A, Hasanvand A (2020) Bupropion ameliorates acetic acid-induced colitis in rat: the involvement of the TLR4\/NF-kB signaling pathway. Inflammation 43:1999\u20132009","journal-title":"Inflammation"},{"key":"829_CR40","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/brainsci10090600","volume":"10","author":"ND Sachinvala","year":"2020","unstructured":"Sachinvala ND, Teramoto N, Stergiou A (2020) Proposed neuroimmune roles of dimethyl fumarate, bupropion, S-adenosylmethionine, and vitamin D3 in affording a chronically Ill patient sustained relief from inflammation and major depression. Brain Sci 10:600","journal-title":"Brain Sci"},{"key":"829_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-017-0177-y","volume":"15","author":"F Seif","year":"2017","unstructured":"Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M (2017) The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal 15:1\u201313","journal-title":"Cell Commun Signal"},{"key":"829_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/revneuro-2018-0027","volume":"30","author":"AS Shariq","year":"2018","unstructured":"Shariq AS, Brietzke E, Rosenblat JD, Pan Z, Rong C, Ragguett R-M, Park C, McIntyre RS (2018) Therapeutic potential of JAK\/STAT pathway modulation in mood disorders. Rev Neurosci 30:1\u20137","journal-title":"Rev Neurosci"},{"key":"829_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neubiorev.2016.02.002","volume":"64","author":"A Slyepchenko","year":"2016","unstructured":"Slyepchenko A, Maes M, K\u00f6hler CA, Anderson G, Quevedo J, Alves GS, Berk M, Fernandes BS, Carvalho AF (2016) T helper 17 cells may drive neuroprogression in major depressive disorder: proposal of an integrative model. Neurosci Biobehav Rev 64:83\u2013100","journal-title":"Neurosci Biobehav Rev"},{"key":"829_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/mol.119.118349","volume":"97","author":"AG Stuebler","year":"2020","unstructured":"Stuebler AG, Jansen M (2020) Bupropion inhibits serotonin type 3AB heteromeric channels at clinically relevant concentrations. Mol Pharmacol 97:171\u2013179","journal-title":"Mol Pharmacol"},{"key":"829_CR45","doi-asserted-by":"publisher","first-page":"13223","DOI":"10.3390\/ijms150813223","volume":"15","author":"J-H Tsai","year":"2014","unstructured":"Tsai J-H, Kuo C-H, Yang P, Cheng K-H, Wang P-W, Chen C-C, Hung C-H (2014) Effects of antidepressants on IP-10 production in LPS-activated THP-1 human monocytes. Int J Mol Sci 15:13223\u201313235","journal-title":"Int J Mol Sci"},{"key":"829_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2014.04.052","volume":"273","author":"Z-F Wang","year":"2014","unstructured":"Wang Z-F, Li Q, Liu S-B, Mi W-L, Hu S, Zhao J, Tian Y, Mao-Ying Q-L, Jiang J-W, Ma H-J (2014) Aspirin-triggered Lipoxin A4 attenuates mechanical allodynia in association with inhibiting spinal JAK2\/STAT3 signaling in neuropathic pain in rats. Neuroscience 273:65\u201378","journal-title":"Neuroscience"},{"key":"829_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuro.2017.04.001","volume":"64","author":"L Yin","year":"2018","unstructured":"Yin L, Dai Q, Jiang P, Zhu L, Dai H, Yao Z, Liu H, Ma X, Qu L, Jiang J (2018) Manganese exposure facilitates microglial JAK2-STAT3 signaling and consequent secretion of TNF-a and IL-1\u03b2 to promote neuronal death. Neurotoxicology 64:195\u2013203","journal-title":"Neurotoxicology"},{"key":"829_CR48","first-page":"85","volume":"44","author":"W Yuan","year":"2011","unstructured":"Yuan W, Williams BN (2011) Monoarthritis induced by bupropion hydrochloride. Psychopharmacol Bull 44:85","journal-title":"Psychopharmacol Bull"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-021-00829-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T17:25:29Z","timestamp":1675531529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-021-00829-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["829"],"URL":"https:\/\/doi.org\/10.1007\/s10787-021-00829-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,3]]},"assertion":[{"value":"9 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"It is important to note that the volunteers gave consent to take part in the study. Tests with the use of human samples have been approved by the ethical committee of Shahid Sadoughi University of Medical Sciences with ethical code: ir.ssu.medicine.rec.1395.337.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}